FIELD: medical biotechnology.
SUBSTANCE: invention relates to the field of medical biotechnology, in particular to the human bladder cancer cell line 190 BlCan KAG deposited in the Specialized Vertebrate Cell Culture Collection of the Russian Cell Culture Collection under registration number RCCC (P) 793D. The specified cell line has stable cultural and morphological characteristics, expresses cancer-testicular antigens NY-ESO1, MAGEA1, PASD1, PRAME. It can be used to create biomedical cell products, in vitro experimental models, to test the activity of various pharmaceuticals, to create diagnostic kits and test systems for the development of new therapeutic approaches and drugs.
EFFECT: invention makes it possible to expand the arsenal of human tumor cell lines that can be used to create cell model systems.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| HUMAN BLADDER CANCER CELL LINE 398 BLCAN KAE | 2020 |
|
RU2742245C1 |
| HUMAN BLADDER CANCER CELL LINE 198 BLCAN RLA | 2019 |
|
RU2733230C1 |
| HUMAN BLADDER CANCER CELL LINE 587 BLCAN TVV | 2020 |
|
RU2742244C1 |
| HUMAN EMBRYONIC RHABDOMYOSARCOMA CELL LINE 862 RMSAR KDD | 2020 |
|
RU2737248C1 |
| APPLICATION OF CELL LINE OF RC291C CLEAR CELL ADENOCARCINOMA | 2018 |
|
RU2673729C1 |
| HUMAN ALVEOLAR SARCOMA CELL LINE 9927 AIS SIO | 2022 |
|
RU2796356C1 |
| APPLICATION OF HUMAN SKIN MELANOMA CELL LINE 388mel | 2018 |
|
RU2675541C1 |
| HUMAN SYNOVIAL SARCOMA CELL LINE 716 SS MNV | 2020 |
|
RU2740800C1 |
| OSTEOGENIC HUMAN SARCOMA CELL LINE 793 OSSAR RVV | 2019 |
|
RU2722867C1 |
| HUMAN OVARIAN CANCER CELL LINE 533 OOS | 2017 |
|
RU2650759C1 |
